Portage Biotech Provides Research and Development Update and Announces NASDAQ Listing Approval Biotech Investing
MindMed Signs Partnership with Swiss Psychedelic Drug Discovery Startup MindShift Compounds AG, Expands Development Pipeline and IP Portfolio with Next-Gen Psychedelic and Empathogenic Compounds Psychedelics Investing
Lexaria Expands R&D Program to Address US$28 Billion Hypertension Market with Addition of Two Human Clinical Studies Biotech Investing
Better Plant's Urban Juve Expands Distribution into New Canadian Retail Locations Cannabis Investing News
Kite Announces New ZUMA-1 Cohort Analysis Evaluating Prophylactic Corticosteroid Use With Yescarta® in Patients With Relapsed or Refractory Large B-cell lymphoma Biotech Investing
Jamieson Wellness Inc. Announces Date of Fourth Quarter and Full Year 2020 Financial Results and Conference Call Pharmaceutical Investing
